NO151225C - Fremgangsmaate ved fremstilling av pasteurellosis-vaksiner - Google Patents

Fremgangsmaate ved fremstilling av pasteurellosis-vaksiner

Info

Publication number
NO151225C
NO151225C NO792748A NO792748A NO151225C NO 151225 C NO151225 C NO 151225C NO 792748 A NO792748 A NO 792748A NO 792748 A NO792748 A NO 792748A NO 151225 C NO151225 C NO 151225C
Authority
NO
Norway
Prior art keywords
procedure
preparation
pasteurellosis
vaccines
pasteurellosis vaccines
Prior art date
Application number
NO792748A
Other languages
English (en)
Norwegian (no)
Other versions
NO151225B (no
NO792748L (no
Inventor
Neil James Livingston Gilmour
William Barr Martin
James Michael Sharp
Peter William Wells
Dennis Arthur Thompson
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of NO792748L publication Critical patent/NO792748L/no
Publication of NO151225B publication Critical patent/NO151225B/no
Publication of NO151225C publication Critical patent/NO151225C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/824—Bacterial vaccine for ovine species, e.g. sheep

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesives Or Adhesive Processes (AREA)
NO792748A 1978-08-24 1979-08-23 Fremgangsmaate ved fremstilling av pasteurellosis-vaksiner NO151225C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7834525 1978-08-24

Publications (3)

Publication Number Publication Date
NO792748L NO792748L (no) 1980-02-26
NO151225B NO151225B (no) 1984-11-26
NO151225C true NO151225C (no) 1985-03-06

Family

ID=10499258

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792748A NO151225C (no) 1978-08-24 1979-08-23 Fremgangsmaate ved fremstilling av pasteurellosis-vaksiner

Country Status (12)

Country Link
US (1) US4346074A (da)
EP (1) EP0020356B1 (da)
AU (1) AU528776B2 (da)
BE (1) BE878430A (da)
CA (1) CA1133829A (da)
DE (1) DE2964721D1 (da)
DK (1) DK149942C (da)
IE (1) IE48402B1 (da)
NO (1) NO151225C (da)
NZ (1) NZ191327A (da)
WO (1) WO1980000412A1 (da)
ZA (1) ZA794416B (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
US5165924A (en) * 1986-01-22 1992-11-24 University Of Guelph Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle
GB2202851B (en) * 1987-03-24 1990-12-19 Nat Res Dev Proteinaceous material of p. haemolytica and vaccine against pasteurella
US5256415A (en) * 1989-03-20 1993-10-26 Louisiana State University Vaccine against bovine respiratory disease (pasteurellosis)
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
MX9301736A (es) * 1992-03-30 1994-01-31 Smithkline Beecham Corp Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
ES2233936T3 (es) 1994-02-04 2005-06-16 Bio Merieux Virus msrv1 asociado a la esclerosis en placas, sus constituyentes nucleicos y sus aplicaciones.
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
FR2737500B1 (fr) 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
US6355255B1 (en) * 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
JP4226657B2 (ja) 1996-11-26 2009-02-18 ベーイーオー メリュー 診断、予防、及び治療のための、多発性硬化症に関連するウイルス性物質及びヌクレオチド断片
FR2760640B1 (fr) * 1997-03-17 1999-05-28 Vetoquinol Sa Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US8541008B2 (en) * 1999-11-19 2013-09-24 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Pharmaceutical compositions and methods to vaccinate against candidiasis
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
JP2008504216A (ja) * 2003-12-02 2008-02-14 サイトイミューン サイエンシズ インコーポレイテッド モノクローナル抗体の生成のための方法および組成物
JP4833862B2 (ja) * 2004-01-28 2011-12-07 サイトイミューン サイエンシズ インコーポレイテッド 官能化コロイド金属組成物および方法
AU2008302035A1 (en) * 2007-09-21 2009-03-26 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
WO2009062151A1 (en) 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
AU2009313615B2 (en) 2008-11-05 2012-11-29 Regents Of The University Of Minnesota Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease
EP2734229B1 (en) 2011-07-22 2019-01-02 Novadigm Therapeutics, Inc. Methods and copositions for vaccinating against staphylococcus aureus
CA2906771A1 (en) 2013-03-15 2014-09-18 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
WO2017155949A1 (en) 2016-03-09 2017-09-14 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Methods and kits for use in preventing and treating vulvovaginal candidiasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1201052A (en) * 1967-09-07 1970-08-05 Lilly Co Eli Vaccines
US3526696A (en) * 1968-02-14 1970-09-01 Lilly Co Eli Shipping fever vaccine
GB1441098A (en) * 1972-03-29 1976-06-30 Wellcome Found Biological preparations
FR2360314A2 (fr) * 1976-08-06 1978-03-03 Fabre Sa Pierre Nouveaux vaccins perfectionnes a base de fractions ribosomales

Also Published As

Publication number Publication date
AU528776B2 (en) 1983-05-12
NZ191327A (en) 1981-07-13
DK149942B (da) 1986-11-03
IE791618L (en) 1980-02-24
US4346074A (en) 1982-08-24
DK176480A (da) 1980-04-24
IE48402B1 (en) 1985-01-09
AU5021479A (en) 1980-02-28
NO151225B (no) 1984-11-26
EP0020356B1 (en) 1983-02-09
DE2964721D1 (en) 1983-03-17
NO792748L (no) 1980-02-26
EP0020356A1 (en) 1981-01-07
BE878430A (fr) 1979-12-17
CA1133829A (en) 1982-10-19
DK149942C (da) 1987-05-04
ZA794416B (en) 1981-02-25
WO1980000412A1 (en) 1980-03-20

Similar Documents

Publication Publication Date Title
NO151225C (no) Fremgangsmaate ved fremstilling av pasteurellosis-vaksiner
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO790257L (no) Fremgangsmaate ved fremstilling av 9-desoksy-9a-metylen-isostere av pgi2
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
NO792240L (no) Fremgangsmaate ved fremstilling av platina-diaminkomplekser
NO791831L (no) Fremgangsmaate for fremstilling av aminotiazoler
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO801796L (no) Fremgangsmaate ved fremstilling av 4-aroylimidazol-2-oner
NO810014L (no) Fremgangsmaate ved fremstilling av kikhostetoksoid
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO792474L (no) Fremgangsmaate ved fremstilling av indanyl-derivater
NO150892C (no) Fremgangsmaate ved fremstilling av slipemasse
NO773682L (no) Fremgangsmaate ved fremstilling av furocumariner
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
NO783143L (no) Fremgangsmaate ved fremstilling av herpesvaksine
NO790543L (no) Fremgangsmaate ved fremstilling av smaksstoff for naeringsmidler
NO780777L (no) Fremgangsmaate ved fremstilling av 1-azaxanthon-3-carboxylsyrer
NO148069C (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenylalanin-methylester
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
NO791440L (no) Fremgangsmaate ved fremstilling av 6-halogen-pregnaner
NO146656C (no) Fremgangsmaate ved fremstilling av xylitolholdige drops
NO147146C (no) Fremgangsmaate ved fremstilling av alkali- og jordalkalimetallbromider.
NO802834L (no) Fremgangsmaate ved fremstilling av 2-amino-3-benzoyl-fenylacetamider
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
NO791220L (no) Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner